Found 10 matching trials
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
PHASE3This is a randomized, open-label, prospective, multicenter phase III superi...
Location
Fudan University Shanghai Cancer Center,
A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma
PHASE2This is a single-arm, open-label, multicenter phase II study evaluating sin...
Location
Sun Yat-sen University Cancer Center
Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL
PHASE2Aim of the trial is to evaluate the safety and efficacy of sintilimab and p...
Location
Sun Yat-sen University Cancer Center
Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
PHASE2The purpose of this multi-center,single arm,phase Ⅱ clinical trail is to de...
Status
Active Not Recruiting
Location
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma
PHASE2The purpose of this study is to evaluate the efficacy and safety of Sintili...
Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma
PHASE2Extranodal NK/T-cell lymphoma is a rare and highly aggressive subtype of no...
Location
Sun Yat-sen Universitiy Cancer Center
Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma
PHASE2The purpose of this study is to evaluate the efficacy and safety of Sintili...
Location
Beijing Tongren Hospital
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
PHASE2This is a single-arm phase 2 study designed to evaluate the safety and effi...
Location
Peking Union Medical College Hospital
Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
PHASE2Extranodal NK/T-cell lymphoma, nasal type (NKTCL) is a common malignant tum...
Location
Cancer Hospital of Fujian Province
GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma
PHASE2This prospective, multicenter study evaluates a response-adapted treatment ...
Location
Fudan University Shanghai Cancer Center